Ameriprise’s Kindred Biosciences, Inc. KIN Stock Holding History

Ameriprise’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,109,851	Closed	-$10.2M	–	4010
2021 Q2	$10.2M	Sell	1,109,851 -890,083	-45%	-$5.18M	﹤0.01%	1933
2021 Q1	$9.9M	Buy	1,999,934 +13,776	+0.7%	+$66.5K	﹤0.01%	1895
2020 Q4	$8.62M	Sell	1,986,158 -5,345	-0.3%	-$21.7K	﹤0.01%	1855
2020 Q3	$8.54M	Buy	1,991,503 +30,214	+2%	+$126K	﹤0.01%	1664
2020 Q2	$8.75M	Buy	1,961,289 +843,456	+75%	+$3.77M	﹤0.01%	1632
2020 Q1	$4.46M	Buy	1,117,833 +72,945	+7%	+$620K	﹤0.01%	1981
2019 Q4	$8.83M	Buy	1,044,888 +270	+0%	+$2.11K	﹤0.01%	1846
2019 Q3	$7.16M	Buy	1,044,618 +620,418	+146%	+$4.55M	﹤0.01%	1955
2019 Q2	$3.53M	Buy	+424,200	New	+$3.66M	﹤0.01%	2443

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Ameriprise's KIN Position: Q3 2021 in Review

Ameriprise sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1,109,851 shares — an estimated $10.2M sold.

Ameriprise first reported a position in KIN in Q2 2019 and held it in 9 quarters. The position peaked at $10.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Ameriprise reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Ameriprise sold 1,109,851 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $10.2M.
Ameriprise first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 9 quarters.
Ameriprise's Kindred Biosciences, Inc. position peaked at $10.2M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.